Search this website

Home
Press
Contact

Menu
Skip to right header navigation
Skip to main content
Skip to primary sidebar

Preservative-free ophthalmic drug delivery

Home
Press
Contact

Press Releases

2020
2019
2017

May 20, 2020
TearClear appoints Dr. Amir Shojaei Chief Development Officer
Apr 15, 2020
TearClear appoints Robert J. Dempsey Chief Executive Officer

May 29, 2019
TearClear Appoints Chief Scientific and Innovation Officer

May 30, 2017
TearClear Completes $4.5 Million Series A Financing and Introduces Leadership Team of Accomplished Ophthalmology Veterans

Facebook0 Tweet0 LinkedIn0 Email0 Print0

Primary Sidebar

Press

Press Releases

TearClear Completes $4.5 Million Series A Financing and Introduces Leadership Team of Accomplished Ophthalmology Veterans
TearClear appoints Robert J. Dempsey Chief Executive Officer
TearClear appoints Dr. Amir Shojaei Chief Development Officer
TearClear Appoints Chief Scientific and Innovation Officer

In the News
Interviews
Downloads

Copyright © 2017–2020 TearClear Corp · All Rights Reserved · Design and development by Sky Dog Technologies

Share this ArticleLike this article? Email it to a friend!

Friend's Email Address

Your Name

Your Email Address

Comments

Email sent!